First-in-human study of the safety and efficacy of TOL101 induction to prevent kidney transplant rejection.
Flechner SM, Mulgoankar S, Melton LB, Waid TH, Agarwal A, Miller SD, Fokta F, Getts MT, Frederick TJ, Herrman JJ, Puisis JP, O'Toole L, Sung R, Shihab F, Wiseman AC, Getts DR.
Flechner SM, et al. Among authors: frederick tj.
Am J Transplant. 2014 Jun;14(6):1346-55. doi: 10.1111/ajt.12698. Epub 2014 Apr 17.
Am J Transplant. 2014.
PMID: 24751150
Free PMC article.
Clinical Trial.